Article
Deciphering the Cardiovascular Potential of Human CD34+ Stem Cells
31 May 2023
Abstract excerpt
Ex vivo monitored human CD34+ stem cells (SCs) injected into myocardium scar tissue have shown real benefits for the recovery of patients with myocardial infarctions. They have been used previously in clinical trials with hopeful results and are expected to be promising for cardiac regenerative medicine following severe acute myocardial infarctions. However, some debates on their potential efficacy in cardiac...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
